{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:25:35Z","timestamp":1792013135598,"version":"4.4.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971743"],"award-info":[{"award-number":["81971743"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82222036"],"award-info":[{"award-number":["82222036"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81827803"],"award-info":[{"award-number":["81827803"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8172900016"],"award-info":[{"award-number":["8172900016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81727804"],"award-info":[{"award-number":["81727804"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91859204"],"award-info":[{"award-number":["91859204"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81729002"],"award-info":[{"award-number":["81729002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230070"],"award-info":[{"award-number":["82230070"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20200083"],"award-info":[{"award-number":["BK20200083"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Nanotechnol."],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1038\/s41565-024-01736-9","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T10:10:03Z","timestamp":1721729403000},"page":"1558-1568","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["A bispecific nanosystem activates endogenous natural killer cells in the bone marrow for haematologic malignancies therapy"],"prefix":"10.1038","volume":"19","author":[{"given":"Yanqin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7273-9056","authenticated-orcid":false,"given":"Yuewen","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juequan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8925-8590","authenticated-orcid":false,"given":"Yueqing","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1242-7365","authenticated-orcid":false,"given":"Siwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"key":"1736_CR1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1200\/JCO.20.03106","volume":"39","author":"C Craddock","year":"2021","unstructured":"Craddock, C. & Friedberg, J. W. Immunotherapy for hematologic malignancies. J. Clin. Oncol. 39, 343\u2013345 (2021).","journal-title":"J. Clin. Oncol."},{"key":"1736_CR2","doi-asserted-by":"crossref","first-page":"8000","DOI":"10.3390\/ijms21218000","volume":"21","author":"JY Noh","year":"2020","unstructured":"Noh, J. Y., Seo, H., Lee, J. & Jung, H. Immunotherapy in hematologic malignancies: emerging therapies and novel approaches. Int. J. Mol. Sci. 21, 8000 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1736_CR3","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror, M. L. et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106, 2912\u20132919 (2005).","journal-title":"Blood"},{"key":"1736_CR4","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3324\/haematol.2022.280803","volume":"108","author":"RF Schlenk","year":"2023","unstructured":"Schlenk, R. F. Acute myeloid leukemia: introduction to a series highlighting progress and ongoing challenges. Haematologica 108, 306\u2013307 (2023).","journal-title":"Haematologica"},{"key":"1736_CR5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/annonc\/mdq178","volume":"21","author":"JL Harousseau","year":"2010","unstructured":"Harousseau, J. L., Dreyling, M. & ESMO Guidelines Working Group Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 21, 155\u2013157 (2010).","journal-title":"Ann. Oncol."},{"key":"1736_CR6","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1182\/blood-2011-05-355743","volume":"118","author":"S Mailankody","year":"2011","unstructured":"Mailankody, S. et al. Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS). Blood 118, 4086\u20134092 (2011).","journal-title":"Blood"},{"key":"1736_CR7","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2014-05-578963","volume":"124","author":"AM Petrich","year":"2014","unstructured":"Petrich, A. M. et al. Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis. Blood 124, 2354\u20132361 (2014).","journal-title":"Blood"},{"key":"1736_CR8","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1182\/blood-2018-04-840793","volume":"131","author":"S Paczesny","year":"2018","unstructured":"Paczesny, S., Pavletic, S. Z. & Bollard, C. M. Introduction to a review series on emerging immunotherapies for hematologic diseases. Blood 131, 2617\u20132620 (2018).","journal-title":"Blood"},{"key":"1736_CR9","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood-2003-03-0954","volume":"103","author":"K Cathcart","year":"2004","unstructured":"Cathcart, K. et al. A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia. Blood 103, 1037\u20131042 (2004).","journal-title":"Blood"},{"key":"1736_CR10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.semcancer.2022.03.016","volume":"86","author":"Q Ye","year":"2022","unstructured":"Ye, Q., Lin, Y., Li, R., Wang, H. & Dong, C. Recent advances of nanodrug delivery system in the treatment of hematologic malignancies. Semin Cancer Biol. 86, 607\u2013623 (2022).","journal-title":"Semin Cancer Biol."},{"key":"1736_CR11","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34744-1","volume":"13","author":"M Panagi","year":"2022","unstructured":"Panagi, M. et al. Polymeric micelles effectively reprogram the tumor microenvironment to potentiate nano-immunotherapy in mouse breast cancer models. Nat. Commun. 13, 7165 (2022).","journal-title":"Nat. Commun."},{"key":"1736_CR12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41536-022-00275-y","volume":"7","author":"S Montserrat-Vazquez","year":"2022","unstructured":"Montserrat-Vazquez, S. et al. Transplanting rejuvenated blood stem cells extends lifespan of aged immunocompromised mice. NPJ Regen. Med 7, 78 (2022).","journal-title":"NPJ Regen. Med"},{"key":"1736_CR13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-018-0709-7","volume":"564","author":"D Li","year":"2018","unstructured":"Li, D. et al. VCAM-1+ macrophages guide the homing of HSPCs to a vascular niche. Nature 564, 119\u2013124 (2018).","journal-title":"Nature"},{"key":"1736_CR14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cell.2014.12.032","volume":"160","author":"OJ Tamplin","year":"2015","unstructured":"Tamplin, O. J. et al. Hematopoietic stem cell arrival triggers dynamic remodeling of the perivascular niche. Cell 160, 241\u2013252 (2015).","journal-title":"Cell"},{"key":"1736_CR15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.matbio.2018.01.007","volume":"67","author":"KH Susek","year":"2018","unstructured":"Susek, K. H. et al. Bone marrow laminins influence hematopoietic stem and progenitor cell cycling and homing to the bone marrow. Matrix Biol. 67, 47\u201362 (2018).","journal-title":"Matrix Biol."},{"key":"1736_CR16","volume":"15","author":"ML Neal","year":"2018","unstructured":"Neal, M. L. et al. The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor. J. Neuroinflammation 15, 73 (2018).","journal-title":"J. Neuroinflammation"},{"key":"1736_CR17","doi-asserted-by":"crossref","first-page":"e151847","DOI":"10.1172\/jci.insight.151847","volume":"7","author":"S Felker","year":"2022","unstructured":"Felker, S. et al. Differential CXCR4 expression on hematopoietic progenitor cells versus stem cells directs homing and engraftment. JCI Insight 7, e151847 (2022).","journal-title":"JCI Insight"},{"key":"1736_CR18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.nantod.2015.04.004","volume":"10","author":"G Fuhrmann","year":"2015","unstructured":"Fuhrmann, G., Herrmann, I. K. & Stevens, M. M. Cell-derived vesicles for drug therapy and diagnostics: opportunities and challenges. Nano Today 10, 397\u2013409 (2015).","journal-title":"Nano Today"},{"key":"1736_CR19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.biomaterials.2017.10.012","volume":"150","author":"T Tian","year":"2018","unstructured":"Tian, T. et al. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials 150, 137\u2013149 (2018).","journal-title":"Biomaterials"},{"key":"1736_CR20","volume":"10","author":"A Rai","year":"2021","unstructured":"Rai, A. et al. Proteomic dissection of large extracellular vesicle surfaceome unravels interactive surface platform. J. Extracell. Vesicles 10, e12164 (2021).","journal-title":"J. Extracell. Vesicles"},{"key":"1736_CR21","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.stem.2021.08.013","volume":"28","author":"KV Woan","year":"2021","unstructured":"Woan, K. V. et al. Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy. Cell Stem Cell 28, 2062\u20132075.e5 (2021).","journal-title":"Cell Stem Cell"},{"key":"1736_CR22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41568-020-0272-z","volume":"20","author":"ND Huntington","year":"2020","unstructured":"Huntington, N. D., Cursons, J. & Rautela, J. The cancer-natural killer cell immunity cycle. Nat. Rev. Cancer 20, 437\u2013454 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"1736_CR23","doi-asserted-by":"crossref","first-page":"e002852","DOI":"10.1136\/jitc-2021-002852","volume":"9","author":"T Nakamura","year":"2021","unstructured":"Nakamura, T. et al. STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation. J. Immunother. Cancer 9, e002852 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"1736_CR24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41577-018-0061-z","volume":"18","author":"L Chiossone","year":"2018","unstructured":"Chiossone, L., Dumas, P. Y., Vienne, M. & Vivier, E. Natural killer cells and other innate lymphoid cells in cancer. Nat. Rev. Immunol. 18, 671\u2013688 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"1736_CR25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41571-020-0426-7","volume":"18","author":"JA Myers","year":"2021","unstructured":"Myers, J. A. & Miller, J. S. Exploring the NK cell platform for cancer immunotherapy. Nat. Rev. Clin. Oncol. 18, 85\u2013100 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1736_CR26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nature12998","volume":"507","author":"M Paolino","year":"2014","unstructured":"Paolino, M. et al. The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells. Nature 507, 508\u2013512 (2014).","journal-title":"Nature"},{"key":"1736_CR27","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/cmi.2013.10","volume":"10","author":"M Cheng","year":"2013","unstructured":"Cheng, M., Chen, Y., Xiao, W., Sun, R. & Tian, Z. NK cell-based immunotherapy for malignant diseases. Cell Mol. Immunol. 10, 230\u2013252 (2013).","journal-title":"Cell Mol. Immunol."},{"key":"1736_CR28","doi-asserted-by":"crossref","first-page":"e002980","DOI":"10.1136\/jitc-2021-002980","volume":"9","author":"C Zhang","year":"2021","unstructured":"Zhang, C. et al. Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity. J. Immunother. Cancer 9, e002980 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"1736_CR29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1158\/2326-6066.CIR-18-0572","volume":"7","author":"R Parihar","year":"2019","unstructured":"Parihar, R. et al. NK cells expressing a chimeric activating receptor eliminate MDSCs and rescue impaired CAR-T cell activity against solid tumors. Cancer Immunol. Res 7, 363\u2013375 (2019).","journal-title":"Cancer Immunol. Res"},{"key":"1736_CR30","volume":"14","author":"TC Luis","year":"2023","unstructured":"Luis, T. C. et al. Perivascular niche cells sense thrombocytopenia and activate hematopoietic stem cells in an IL-1 dependent manner. Nat. Commun. 14, 6062 (2023).","journal-title":"Nat. Commun."},{"key":"1736_CR31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.stem.2017.11.006","volume":"22","author":"D Duarte","year":"2018","unstructured":"Duarte, D. et al. Inhibition of endosteal vascular niche remodeling rescues hematopoietic stem cell loss in AML. Cell Stem Cell 22, 64\u201377.e6 (2018).","journal-title":"Cell Stem Cell"},{"key":"1736_CR32","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1182\/blood-2009-04-215020","volume":"114","author":"M Hiasa","year":"2009","unstructured":"Hiasa, M. et al. GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-\u03b1 converting enzyme (TACE). Blood 114, 4517\u2013452 (2009).","journal-title":"Blood"},{"key":"1736_CR33","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.immuni.2015.05.018","volume":"42","author":"J Helft","year":"2015","unstructured":"Helft, J. et al. GM-CSF mouse bone marrow cultures comprise a heterogeneous population of CD11c+MHCII+ macrophages and dendritic cells. Immunity 42, 1197\u20131211 (2015).","journal-title":"Immunity"},{"key":"1736_CR34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cell.2017.11.034","volume":"172","author":"I Mitroulis","year":"2018","unstructured":"Mitroulis, I. et al. Modulation of myelopoiesis progenitors is an integral component of trained immunity. Cell 172, 147\u2013161.e112 (2018).","journal-title":"Cell"},{"key":"1736_CR35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.790309","volume":"12","author":"C Bono","year":"2021","unstructured":"Bono, C. et al. GM-CSF programs hematopoietic stem and progenitor cells during candida albicans vaccination for protection against reinfection. Front Immunol. 12, 790309 (2021).","journal-title":"Front Immunol."},{"key":"1736_CR36","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/sj.cr.7310017","volume":"16","author":"Y Shi","year":"2006","unstructured":"Shi, Y. et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don\u2019t know. Cell Res. 16, 126\u2013133 (2006).","journal-title":"Cell Res."},{"key":"1736_CR37","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.addr.2012.01.012","volume":"64","author":"SA Low","year":"2012","unstructured":"Low, S. A. & Kope\u010dek, J. Targeting polymer therapeutics to bone. Adv. Drug Deliv. Rev. 64, 1189\u20131204 (2012).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1736_CR38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13045-020-01014-w","volume":"14","author":"S Liu","year":"2021","unstructured":"Liu, S. et al. NK cell-based cancer immunotherapy: from basic biology to clinical development. J. Hematol. Oncol. 14, 7 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"1736_CR39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13287-021-02277-x","volume":"12","author":"MG Lamb","year":"2021","unstructured":"Lamb, M. G., Rangarajan, H. G., Tullius, B. P. & Lee, D. A. Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future. Stem Cell Res. Ther. 12, 211 (2021).","journal-title":"Stem Cell Res. Ther."},{"key":"1736_CR40","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1158\/2326-6066.CIR-21-0843","volume":"10","author":"N Colomar-Carando","year":"2022","unstructured":"Colomar-Carando, N. et al. Exploiting natural killer cell engagers to control pediatric B-cell precursor acute lymphoblastic leukemia. Cancer Immunol. Res 10, 291\u2013302 (2022).","journal-title":"Cancer Immunol. Res"},{"key":"1736_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.blre.2016.08.007","volume":"31","author":"GS Kannan","year":"2017","unstructured":"Kannan, G. S., Aquino-Lopez, A. & Lee, D. A. Natural killer cells in malignant hematology: a primer for the non-immunologist. Blood Rev. 31, 1\u201310 (2017).","journal-title":"Blood Rev."},{"key":"1736_CR42","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1182\/blood-2016-08-734798","volume":"129","author":"MS Shafat","year":"2017","unstructured":"Shafat, M. S. et al. Leukemic blasts program bone marrow adipocytes to generate a protumoral microenvironment. Blood 129, 1320\u20131332 (2017).","journal-title":"Blood"},{"key":"1736_CR43","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1200\/JCO.19.03148","volume":"38","author":"PJ Saylor","year":"2020","unstructured":"Saylor, P. J. et al. Bone health and bone-targeted therapies for prostate cancer: ASCO endorsement of a cancer care Ontario guideline. J. Clin. Oncol. 38, 1736\u20131743 (2020).","journal-title":"J. Clin. Oncol."},{"key":"1736_CR44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41551-019-0503-3","volume":"4","author":"NJ Shah","year":"2020","unstructured":"Shah, N. J. et al. A biomaterial-based vaccine eliciting durable tumour-specific responses against acute myeloid leukaemia. Nat. Biomed. Eng. 4, 40\u201351 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"1736_CR45","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/leu.2017.259","volume":"32","author":"B Kumar","year":"2018","unstructured":"Kumar, B. et al. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion. Leukemia 32, 575\u2013587 (2018).","journal-title":"Leukemia"},{"key":"1736_CR46","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1182\/blood-2015-03-635599","volume":"127","author":"A Vasanthakumar","year":"2016","unstructured":"Vasanthakumar, A. et al. Brca1 deficiency causes bone marrow failure and spontaneous hematologic malignancies in mice. Blood 127, 310\u2013313 (2016).","journal-title":"Blood"},{"key":"1736_CR47","doi-asserted-by":"crossref","first-page":"e002758","DOI":"10.1136\/jitc-2021-002758","volume":"9","author":"W-L Yan","year":"2021","unstructured":"Yan, W.-L., Wu, C.-C., Shen, K.-Y. & Liu, S.-J. Activation of GM-CSF and TLR2 signaling synergistically enhances antigen-specific antitumor immunity and modulates the tumor microenvironment. J. Immunother. Cancer 9, e002758 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"1736_CR48","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/molcells.2016.0160","volume":"39","author":"YR Na","year":"2016","unstructured":"Na, Y. R., Jung, D., Gu, G. J. & Seok, S. H. GM-CSF grown bone marrow derived cells are composed of phenotypically different dendritic cells and macrophages. Mol. Cells 39, 734\u2013741 (2016).","journal-title":"Mol. Cells"},{"key":"1736_CR49","volume":"7","author":"MJ Robinson","year":"2022","unstructured":"Robinson, M. J. et al. Long-lived plasma cells accumulate in the bone marrow at a constant rate from early in an immune response. Sci. Immunol. 7, eabm8389 (2022).","journal-title":"Sci. Immunol."},{"key":"1736_CR50","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41551-018-0310-2","volume":"2","author":"Q Hu","year":"2018","unstructured":"Hu, Q. et al. Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacy. Nat. Biomed. Eng. 2, 831\u2013840 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"1736_CR51","volume":"8","author":"PM Tang","year":"2017","unstructured":"Tang, P. M. et al. Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development. Nat. Commun. 8, 14677 (2017).","journal-title":"Nat. Commun."},{"key":"1736_CR52","doi-asserted-by":"crossref","first-page":"1596016","DOI":"10.1080\/20013078.2019.1596016","volume":"8","author":"D Bachurski","year":"2019","unstructured":"Bachurski, D. et al. Extracellular vesicle measurements with nanoparticle tracking analysis \u2013 an accuracy and repeatability comparison between NanoSight NS300 and ZetaView. J Extracell. Vesicles 8, 1596016 (2019).","journal-title":"J Extracell. Vesicles"},{"key":"1736_CR53","doi-asserted-by":"crossref","first-page":"128217","DOI":"10.1016\/j.cej.2020.128217","volume":"409","author":"P Li","year":"2021","unstructured":"Li, P. et al. Synergistic ferroptosis and macrophage re-polarization using engineering exosome-mimic M1 nanovesicles for cancer metastasis suppression. Chem. Eng. J. 409, 128217 (2021).","journal-title":"Chem. Eng. J."},{"key":"1736_CR54","doi-asserted-by":"crossref","first-page":"102708","DOI":"10.1016\/j.jaut.2021.102708","volume":"123","author":"S Rajendran","year":"2021","unstructured":"Rajendran, S. et al. IL-17 is expressed on beta and alpha cells of donors with type 1 and type 2 diabetes. J Autoimmun. 123, 102708 (2021).","journal-title":"J Autoimmun."},{"key":"1736_CR55","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1167\/iovs.16-20824","volume":"58","author":"MB Gutowski","year":"2017","unstructured":"Gutowski, M. B., Wilson, L., Van Gelder, R. N. & Pepple, K. L. In vivo bioluminescence imaging for longitudinal monitoring of inflammation in animal models of uveitis. Invest. Ophthalmol. Vis. Sci. 58, 1521\u20131528 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1736_CR56","doi-asserted-by":"crossref","first-page":"e1518","DOI":"10.1002\/ctm2.1518","volume":"13","author":"Z Dai","year":"2023","unstructured":"Dai, Z. et al. Gender dimorphism in hepatocarcinogenesis-DNA methylation modification regulated X-chromosome inactivation escape molecule XIST. Clin. Transl. Med. 13, e1518 (2023).","journal-title":"Clin. Transl. Med."},{"key":"1736_CR57","doi-asserted-by":"publisher","unstructured":"Zhang, Y. et al. A bispecific nanosystem activates endogenous NK cells in the bone marrow for hematologic malignancies therapy. figshare https:\/\/doi.org\/10.6084\/m9.figshare.25663173 (2024).","DOI":"10.6084\/m9.figshare.25663173"}],"updated-by":[{"DOI":"10.1038\/s41565-024-01796-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000}}],"container-title":["Nature Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41565-024-01736-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41565-024-01736-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41565-024-01736-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T01:04:07Z","timestamp":1729213447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41565-024-01736-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1736"],"URL":"https:\/\/doi.org\/10.1038\/s41565-024-01736-9","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41565-024-01796-x","asserted-by":"object"}]},"ISSN":["1748-3387","1748-3395"],"issn-type":[{"value":"1748-3387","type":"print"},{"value":"1748-3395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,23]]},"assertion":[{"value":"4 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41565-024-01796-x","URL":"https:\/\/doi.org\/10.1038\/s41565-024-01796-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}